Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

The Royal Marsden given the green light for the Oak Cancer centre, a major new treatment and research facility

Sutton Council has resolved to grant planning permission for The Royal Marsden NHS Foundation Trust’s new, state-of-the-art cancer facility.

07 November 2019

The Oak Cancer Centre will enable The Royal Marsden to help people with cancer in London and the South East for decades to come, and to discover breakthroughs in cancer research that will benefit patients not just in and around Sutton but throughout the UK and around the world.

The Royal Marsden is a world-renowned centre of excellence with an international reputation for ground-breaking research, pioneering the very latest cancer treatments and technologies and specialising in cancer diagnosis and education. It consists of hospitals in both Chelsea and Sutton, with some of the facilities and infrastructure in Sutton dating back to the 1960s.

The Royal Marsden Cancer Charity is raising £70 million for the Oak Cancer Centre. Named in recognition of Oak Foundation which has donated £25 million- the largest donation the charity has ever received- the centre will replace some of these facilities with modern, carefully designed spaces. 

A new Rapid Diagnostic Centre will use the very latest technology to provide faster diagnosis for more people, helping to save lives by diagnosing cancer earlier when treatment is more likely to be successful.

A new Medical Day Unit will enable patients to enjoy peace and quiet while receiving chemotherapy, and patients visiting the new outpatients department will be able to undergo blood tests, see their consultant and collect a prescription all on the same floor.

Importantly, the centre will bring together over 400 researchers who are currently dispersed across the site, in spaces designed to encourage collaboration and help speed up the development of new treatments.

The planning application received an unprecedented level of public support with over 100 positive comments submitted to the Council in support of the plans. Permission was approved unanimously, subject to conditions of a Section 106 Agreement (S106), which is a plan to mitigate the impact of the build on the local community and infrastructure. Building work is due to begin next summer, with the centre due to open in 2022.  

Chief Executive of The Royal Marsden, Cally Palmer CBE, said:

“We are delighted Sutton Council has approved our plans for the Oak Cancer Centre. This state of the art facility, with a focus on early diagnosis and accelerating developments in research, will allow us to be there for everyone who needs us for decades to come. 

“We have worked closely with the London Borough of Sutton, the local community and clinical professionals to design these proposals, and are excited that the centre will be at the heart of the developing London Cancer Hub- the London Borough of Sutton’s master plan to create a leading life science and healthcare district specialising in cancer research and treatment. I’m extremely grateful to everyone who is supporting the Oak Cancer Centre, in particular Oak Foundation and all our other generous donors.”

None of this would be possible without the supporters of The Royal Marsden Cancer Charity. In addition to the lead gift from Oak Foundation, we are incredibly grateful to the following donors who have pledged or given significantly to the fundraising appeal, which now stands at £59 million; Kuok Group Foundation, the Charles Wolfson Charitable Trust, Alex Beard and Emma Vernetti, Goldman Sachs Gives, the Garfield Weston Foundation and Ralph Lauren Corporation.  

This state of the art facility, with a focus on early diagnosis and accelerating developments in research, will allow us to be there for everyone who needs us for decades to come.

Chief Executive of The Royal Marsden, Cally Palmer CBE